Nieuws
Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...
The Canadian Press on MSN2d
Health Canada approves Ozempic to reduce kidney deterioration in people with diabetes
TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...
Health Canada has approved Ozempic for use by Type 2 diabetes patients to reduce the risk of further kidney damage.
(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney ...
Asianet Newsable on MSN1d
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1 mg demonstrated ...
Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and ...
Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...
The Canadian Press on MSN1d
Quebec City using artificial intelligence to manage traffic, reduce congestion
According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...
The Pharmacy and Poisons Board (PPB) has warned Kenyans against the use of off-label semaglutide compounds, also known as Ozempic, for weight loss, saying the drug is strictly a Prescription-Only ...
Sommige resultaten zijn verborgen omdat ze mogelijk niet toegankelijk zijn voor u.
Niet-toegankelijke resultaten weergeven
Feedback